These results are consistent with previous results in colon cancer, glioblastoma, and ovarian cancer, in which IL-8 has been demonstrated to promote angiogenesis and tumor growth both in vitro and in vivo [41]. Here, CXCL8 is linked to ovarian carcinoma.